de' Angelis Gian Luigi, Fornaroli Fabiola, de' Angelis Nicola, Magiteri Barbara, Bizzarri Barbara
Pediatric Gastroenterologic Unit, University of Parma, Parma, Italy.
Am J Gastroenterol. 2007 Aug;102(8):1749-57; quiz 1748, 1758. doi: 10.1111/j.1572-0241.2007.01209.x.
Although capsule endoscopy (CE) is becoming an increasingly popular procedure, only recently data on its clinical application in pediatric gastroenterology are just emerging. Our aim is to investigate the diagnostic value of CE in small intestine diseases and to determine its safety, tolerance, and applicability in a large number of pediatric patients referred to our Tertiary Center of Pediatric Gastroenterology Unit, University of Parma.
A total of 87 Italian patients, 49 of which were male with an age range from 18 months to 18 yr with a suspected small-bowel disease (inflammatory bowel disease 37%, polyps 38%, obscure gastrointestinal bleeding 24%, malabsorption 1%), were investigated with the M2A capsule (GIVEN((R)) Imaging Ltd., Yoqneam, Israel).
A total of 77 patients swallowed the capsule, while in 10 it was endoscopically positioned (age range 1.5-11 yr, median age 5.3 yr). Eighty patients naturally evacuated the capsule, one patient needed surgery. The capsule evidenced pathological findings in 62 patients (71%), ileal lymphoid nodular hyperplasia in four subjects (5%), it was negative in 18 subjects (21%), and technically failed in three subjects (3%). In 21 out of 28 patients with known polyposis and in all the five patients with suspected polyposis, small-bowel polyps were found. In 16 out of 22 patients suffering from known inflammatory bowel disease (Crohn's disease colitis or indeterminate colitis), small intestine lesions were found. CE examination identified a possible small intestine bleeding source in 13 out of 21 patients with suspected obscure gastrointestinal bleeding. In 5 out of 10 patients with suspected small-bowel inflammatory disease, CE evidenced ileum lesions suggesting Crohn's disease, which was subsequently confirmed through diagnostic procedures and the clinical history. A patient with malabsorption presented a negative capsule study.
Our experience, which includes the largest number of pediatric patients and the youngest child reported in literature, confirms that CE is a very useful system for the clinical work in suspected small-bowel diseases in infancy. The high rate of positive examination is due to the very careful selection of the patients, obligatory to conduct a safe examination since CE is not highly tested in children.
尽管胶囊内镜检查(CE)正变得越来越普及,但关于其在儿科胃肠病学临床应用的数据直到最近才刚刚出现。我们的目的是研究CE在小肠疾病中的诊断价值,并确定其在大量转诊至我们帕尔马大学儿科胃肠病学三级中心的儿科患者中的安全性、耐受性和适用性。
共87例意大利患者,其中49例为男性,年龄范围从18个月至18岁,怀疑患有小肠疾病(炎症性肠病37%,息肉38%,不明原因胃肠道出血24%,吸收不良1%),接受了M2A胶囊(Given Imaging Ltd.,以色列约克尼姆)检查。
共有77例患者吞下了胶囊,10例通过内镜放置(年龄范围1.5 - 11岁,中位年龄5.3岁)。80例患者自然排出胶囊,1例患者需要手术。胶囊在62例患者(71%)中发现了病理结果,4例患者(5%)发现回肠淋巴小结增生,18例患者(21%)检查结果为阴性,3例患者(3%)技术失败。在28例已知息肉病的患者中有21例以及所有5例疑似息肉病的患者中发现了小肠息肉。在22例已知炎症性肠病(克罗恩病结肠炎或不确定性结肠炎)的患者中有16例发现了小肠病变。CE检查在21例疑似不明原因胃肠道出血的患者中有13例确定了可能的小肠出血源。在10例疑似小肠炎症性疾病的患者中有5例,CE发现回肠病变提示克罗恩病,随后通过诊断程序和临床病史得到证实。1例吸收不良患者的胶囊检查结果为阴性。
我们的经验包括文献报道中数量最多的儿科患者和最小的儿童,证实了CE对于婴儿疑似小肠疾病的临床工作是一个非常有用的系统。阳性检查率高是由于对患者进行了非常仔细的选择,因为CE在儿童中尚未经过充分测试,所以进行安全检查是必要的。